Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remission.

INTRODUCTION Despite continuous achievements over the last 20 years in biological understanding and therapeutic approaches, patients suffering from acute leukemias usually have a poor prognosis. Despite the fact that initial disease can usually be controlled by cytotoxic chemotherapy, most patients will relapse and eventually die. Thus, attempts to prevent leukemia recurrence have been the target of ongoing investigations. Much effort has [...]